EXECUTIVE TRANSITION AND SEPARATION AGREEMENT AND GENERAL RELEASEExecutive Transition and Separation Agreement • October 5th, 2016 • Rennova Health, Inc. • Services-testing laboratories • Delaware
This Executive Transition and Separation Agreement and General Release ("Agreement") is by and among Rennova Health, Inc. and Medytox Solutions, Inc. (collectively, the "Company"), and Jason P. Adams ("Executive"), and will become effective upon the 8th day after execution by the Executive, if not revoked, as set forth in Section 12 below.
STOCK PURCHASE AGREEMENT BY AND AMONG GENOMAS, INC., THE SELLERS SET FORTH IN SCHEDULE D HERETO, MEDYTOX DIAGNOSTICS, INC., and RENNOVA HEALTH, INC. September 29, 2016Stock Purchase Agreement • October 5th, 2016 • Rennova Health, Inc. • Services-testing laboratories • Florida
THIS STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of September 29, 2016, is by and among GENOMAS, INC., a Delaware corporation (the “Company”), the stockholder sellers set forth in Schedule D hereto (each, a “Seller” and, collectively, the “Sellers”), MEDYTOX DIAGNOSTICS, INC., a Florida corporation (“Purchaser”), a wholly-owned subsidiary of RENNOVA HEALTH, INC., a Delaware corporation (“Rennova”), and Rennova. The Company, Sellers, Purchaser and Rennova are sometimes referred to herein collectively as the “Parties” and each individually as a “Party.”
